ELUT supply chain intelligence for Elutia Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Elutia Inc. (ELUT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BERKELEY | BERKELEY | 92% | SimpliDerm is now supplied to Elutia through a long-term supply agreement with Berkeley, the acquiror of our Orthobiologics Business. |
| COOK-BIOTECH-INCORPORATED | COOK-BIOTECH-INCORPORATED | 92% | The porcine SIS-ECM for our Cardiovascular products is supplied by Cook Biotech Incorporated ("Cook"), now owned by Evergen, through a long-term supply agreement. |
| EVERGEN | EVERGEN | 80% | The porcine SIS-ECM for our Cardiovascular products is supplied by Cook Biotech Incorporated ("Cook"), now owned by Evergen, through a long-term supply agreement. |
| BSX | Boston Scientific Corporation | 72% | our commercial partners and independent sales agents, which subjects us to various risks; ● because we depend upon a limited number of third-party suppliers and manufacturers and, in certain cases, e… |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from BSX grap… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from ELUT graph: ves to further expand our footprint and accelerate our sales. 78 Table of Contents We also sell legacy products into… |
| MDT | Medtronic plc | 72% | ves to further expand our footprint and accelerate our sales. 78 Table of Contents We also sell legacy products into the Cardiovascular market. In Cardiovascular, we sell our specialized porcine sm… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from BSX grap… |
| BSX | Boston Scientific Corporation | 72% | CanGaroo, are sold through both our internal sales force and independent sales agents and our commercial 25 Table of Contents partner, Boston Scientific Corporation. We believe the commercializatio… |
| LGND | Ligand Pharmaceuticals Incorporated | 72% | largely stabilize, or increase at modest rates, in the near future through the identification of efficiencies as we grow. We may, however, still experience more significant expense increases to the e… |
| LGND | Ligand Pharmaceuticals Incorporated | 72% | Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: largely stabilize, or increase at m… |
| MDT | Medtronic plc | 72% | ned structural integrity and superior handling capabilities, which may mitigate inflammation and enhance tissue incorporation, leading to a better healing experience as compared to other ADM products… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from MDT graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from MDT grap… |
| BERKELEY-BIOLOGICS-LLC | BERKELEY-BIOLOGICS-LLC | 62% | uence; ● our ability to raise funds in the future in the amounts and at the times needed; ● the continued and future acceptance of our products by the medical community; ● our dependence on independe… |
| CARDIAC-PACEMAKERS-INC | CARDIAC-PACEMAKERS-INC | 62% | uence; ● our ability to raise funds in the future in the amounts and at the times needed; ● the continued and future acceptance of our products by the medical community; ● our dependence on independe… |
| CORMATRIX-CARDIOVASCULAR-INC | CORMATRIX-CARDIOVASCULAR-INC | 62% | Less: current operating lease liabilities ( 355 ) Long-term operating lease liabilities $ 3,587 Note 9. Intangible Assets On May 31, 2017, the Company completed an asset purchase agreem… |
| MEDTRONIC-SOFAMOR-DANEK-USA-INC | MEDTRONIC-SOFAMOR-DANEK-USA-INC | 62% | are our next-generation biologic scaffolds combined with local antibiotic delivery; any statements and information concerning our future interactions with the U.S. Food and Drug Administration (“FDA”… |
| SWK-FUNDING-LLC | SWK-FUNDING-LLC | 62% | Less: current operating lease liabilities ( 355 ) Long-term operating lease liabilities $ 3,587 Note 9. Intangible Assets On May 31, 2017, the Company completed an asset purchase agreem… |
| TIGER-AESTHETICS-MEDICAL-LLC | TIGER-AESTHETICS-MEDICAL-LLC | 62% | are our next-generation biologic scaffolds combined with local antibiotic delivery; any statements and information concerning our future interactions with the U.S. Food and Drug Administration (“FDA”… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ELUT-DEBT | Debt stack $26.1M | 90% | Market cache reports total debt of $26.1M. |
| ELUT-DEBT-9274 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| ELUT-DEBT-9273 | Warrants outstanding: 607000 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ELUT-OWNER-AIGH-CAPITAL-MANAGEMENT-LLC | AIGH Capital Management LLC | 90% | 13F overlay lists AIGH Capital Management LLC as top holder; 36 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | 100.00 | 2 | |
| LONA | LeonaBio, Inc. | 100.00 | 2 | |
| TLX | Telix Pharmaceuticals Limited | 100.00 | 2 | |
| NSPR | InspireMD, Inc. | 100.00 | 2 | |
| OVID | Ovid Therapeutics Inc. | 100.00 | 2 | |
| PLX | Protalix BioTherapeutics, Inc. | 100.00 | 2 | |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 100.00 | 2 | |
| SGMO | Sangamo Therapeutics, Inc. | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 | |
| CRMD | CorMedix Inc. | 100.00 | 2 | |
| AGEN | Agenus Inc. | 100.00 | 2 | |
| BWAY | BrainsWay Ltd. | 100.00 | 2 | |
| PLSE | Pulse Biosciences, Inc. | 100.00 | 2 | |
| DRTS | Alpha Tau Medical Ltd. | 100.00 | 2 | |
| VKTX | Viking Therapeutics, Inc. | 100.00 | 2 | |
| ICCM | IceCure Medical Ltd | 100.00 | 2 | |
| MDT | Medtronic plc | 100.00 | 1 | ['customer', 'supplier'] |
| PEN | Penumbra, Inc. | 100.00 | 2 | |
| DXCM | DexCom, Inc. | 50.00 | 2 | |
| CBIH | Cannabis Bioscience International Holdings, Inc. | 50.00 | 2 |